Josh Gottheimer, U.S. Representative

Josh Gottheimer

DemocratNJ05houseFiled Jul 16, 2025
11 total filings on record
Trades
18
Tickers
15
Max Value
$1K-$15K
Flags
5 Found

Trade Performance Intelligence

Score: 3/10
Trades Tracked
0/18
Profitable
N/A
Avg Change
N/A
Days Since
279 days

Performance calculated from trade date to most recent market close. Real-time stock data from Financial Modeling Prep. This is not financial advice.

Stock Price at Trade vs. Today

Real market data showing how each stock moved since the congress member traded it.

Suspicious Timing Detected

5 flags
1.

Josh Gottheimer sold $1,001 - $15,000 in $PFE on 2025-06-03, 2 days before the 'Treat and Reduce Obesity Act of 2025' (S1973) was introduced, which aims to expand Medicare coverage for obesity treatments.

2.

Josh Gottheimer sold $1,001 - $15,000 in $PFE on 2025-06-03, 8 days before the 'Medical Research for Our Troops Act' (HR3906) was introduced, proposing to restore $1.181 billion to the Defense Health Agency for military health R&D.

3.

Josh Gottheimer sold $1,001 - $15,000 in $TSLA on 2025-06-05, 40 days before the 'STOP China Act' (HR4361) was introduced, which aims to prohibit federal funds for vehicles and vehicle technologies from Chinese entities.

4.

Josh Gottheimer sold $1,001 - $15,000 in $TSLA on 2025-06-05, 42 days before the 'Price Gouging Prevention Act of 2025' (HR4528) was introduced, which directly limits corporate profitability for large-cap companies.

5.

Josh Gottheimer sold $1,001 - $15,000 in $CRM on 2025-06-04, 47 days before the 'AI Accountability and Personal Data Protection Act' (S2367) was introduced, which introduces a Federal tort for data exploitation.

These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.

Share This Filing

All Transactions

BUY$1K-$15K
$AVGOBroadcom Inc. - Common Stock
Jun 25, 2025 \u2022 joint
BUY$1K-$15K
$CVNACarvana Co. Class A Common Stock
Jun 20, 2025 \u2022 joint
BUY$1K-$15K
$CBChubb Limited Common Stock
Jun 13, 2025 \u2022 joint
BUY$1K-$15K
$NETCloudflare, Inc. Class A Common Stock
Jun 20, 2025 \u2022 joint
BUY$1K-$15K
$INSMInsmed Incorporated - Common Stock
Jun 16, 2025 \u2022 joint
BUY$1K-$15K
$NVDANVIDIA Corporation - Common Stock
Jun 24, 2025 \u2022 joint
SELL$1K-$15K
$AKAMAkamai Technologies, Inc. - Common Stock
Jun 3, 2025 \u2022 joint
PARTIAL SELL$1K-$15K
$COPConocoPhillips Common Stock
Jun 24, 2025 \u2022 joint
SELL$1K-$15K
$FISFidelity National Information Services, Inc. Common Stock
Jun 3, 2025 \u2022 joint
PARTIAL SELL$1K-$15K
$MCDMcDonald's Corporation Common Stock
Jun 20, 2025 \u2022 joint

Connected Legislative Activity

10 signals

These bills and contracts share tickers or sectors with this filing's trades.

BillS1973bullish

Treat and Reduce Obesity Act of 2025

The Treat and Reduce Obesity Act of 2025 (S.1973) is in early legislative stages, aiming to expand Medicare coverage for obesity treatments, including GLP-1 agonists and intensive behavioral therapy. This bill, if enacted, would significantly increase the total addressable market for pharmaceutical companies producing obesity drugs and manufacturers of related medical devices. Companies like Eli Lilly and Company ($LLY) and Novo Nordisk A/S ($NVO) are positioned to benefit from this potential market expansion.

4/10
Jun 5, 2025
$LLY$NVO$PFE$AMGN$JNJ$ABT
BillHR4361bullish

STOP China Act

The STOP China Act (HR4361) aims to prohibit federal funds for vehicles and vehicle technologies from Chinese entities, directing procurement towards US-based manufacturers. This bill is in the early stages, having been referred to two House committees, but has a companion bill (S1711) in the Senate, indicating bipartisan interest. The legislation creates a protected market for American vehicle and component manufacturers in federally funded projects.

5/10
Jul 15, 2025
$GM$F$TSLA$OSK
BillHR4668bearish

End the Vaccine Carveout Act

The 'End the Vaccine Carveout Act' removes liability protections for vaccine manufacturers, directly increasing their legal and operational risks. This bill, if enacted, will significantly alter the risk profile and profitability of pharmaceutical companies producing vaccines. Companies like Pfizer, Moderna, GSK, and Johnson & Johnson face increased litigation exposure.

3/10
Jul 23, 2025
$PFE$MRNA$GSK$JNJ
Billneutral

BLUE TECH INC.: $15.6M Department of Homeland Security Contract

This $15.6 million contract for Salesforce software licenses to BLUE TECH INC. will indirectly benefit Salesforce ($CRM) as the primary software provider, representing a routine but consistent revenue stream for the company.

4/10
Sep 19, 2025
$CRM
BillHR3906neutral

Medical Research for Our Troops Act

The 'Medical Research for Our Troops Act' (HR3906) proposes to restore $1.181 billion to the Defense Health Agency for military health R&D. This bill is in the early stages, having been referred to the House Committee on Appropriations on June 11, 2025. Companies with defense contracts in clinical research, medical devices, and pharmaceuticals would benefit if this funding is restored.

5/10
Jun 11, 2025
$JNJ$PFE$MRK$MDT$SYK
BillHR4528bearish

Price Gouging Prevention Act of 2025

The Price Gouging Prevention Act of 2025 directly limits corporate profitability for large-cap companies during 'exceptional market shock' events by mandating pre-shock margin maintenance. This legislation increases regulatory risk and caps potential upside for companies with significant market power across all sectors, leading to decreased profitability during crises. All major corporations face reduced profit potential and increased compliance costs.

5/10
Jul 17, 2025
$WMT$AMZN$XOM$CVX$JNJ$PFE
BillS2367bearish

AI Accountability and Personal Data Protection Act

The 'AI Accountability and Personal Data Protection Act' (S.2367) introduces a Federal tort for data exploitation without prior consent, including AI training, directly increasing compliance costs and litigation risk for technology companies. Meta Platforms ($META) has experienced a 30-day decline of 13.25%, Alphabet ($GOOGL) a 0.3% decline, Amazon ($AMZN) a 2.81% decline, Microsoft ($MSFT) a 9.2% decline, and Salesforce ($CRM) an 8.12% decline, while NVIDIA ($NVDA) and IBM ($IBM) saw smaller declines of 3.11% and 3.82% respectively over the same period.

4/10
Jul 21, 2025
$GOOGL$META$AMZN$MSFT$CRM
BillS2857neutral

Protecting Free Vaccines Act of 2025

The 'Protecting Free Vaccines Act of 2025' (S.2857) is in the early stages, having been referred to committee. This bill aims to codify existing mandates for ACIP-recommended immunization coverage, ensuring stable revenue for vaccine manufacturers and health insurers by preventing future disruptions to current vaccine coverage. It does not introduce new market drivers or significant changes to demand.

4/10
Sep 18, 2025
$PFE$MRNA$JNJ$UNH$ELV$CVS
BillHR4548bullish

Small Nonprofit Retirement Security Act of 2025

The Small Nonprofit Retirement Security Act of 2025 expands tax credits for retirement plan startup costs and auto-enrollment to tax-exempt small employers, directly increasing the total addressable market for financial services and payroll processing companies. This creates a new revenue stream for providers of retirement plan administration, payment processing, and financial data services.

4/10
Jul 21, 2025
$ADP$PAYX$FIS$SPGI$MSCI$V
BillHR5448bullish

Protecting Free Vaccines Act

The 'Protecting Free Vaccines Act' (HR5448) is an early-stage bill that, if enacted, would mandate no-cost coverage for ACIP-recommended vaccines by Medicare, Medicaid, CHIP, and private insurers until January 1, 2030. This would directly increase demand for vaccine manufacturers and shift cost burdens to health insurers and government programs. Vaccine manufacturers are positioned for sustained revenue growth, while health insurers face increased costs.

5/10
Sep 18, 2025
$PFE$MRNA$GSK$NVS$JNJ$UNH

Live Charts

$AKAM● Sold
$AVGO● Bought
$CVNA● Bought
$CB● Bought
$NET● Bought
$COP● Sold

Other Filings by Josh Gottheimer

Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.